Real-time enrollment status for this epidermolysis bullosa clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT04173650 |
| Recruiting Status | Recruiting |
| Condition | Epidermolysis Bullosa |
| Phase | Clinical Trial |
| Target Enrollment | 8 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Aegle Therapeutics |
| Last Updated on CT.gov | June 25, 2025 (Jun 25, 2025) |
As of March 2, 2026: Clinical trial NCT04173650 is currently recruiting participants. This clinical trial study for epidermolysis bullosa is actively seeking new participants at 3 locations across the United States. The study is sponsored by Aegle Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04173650 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04173650 was last updated Jun 25, 2025 (June 25, 2025). HelloStudys verifies this status automatically.